American Journal of Respiratory Cell and Molecular Biology. Vol. 28, pp. 249-256, 2003
© 2003 American Thoracic Society DOI: 10.1165/rcmb.4896
Surfactant Protein A and D Differently Regulate the Immune Response to Nonmucoid Pseudomonas aeruginosa and Its Lipopolysaccharide
Philip Bufler,
Bettina Schmidt,
Daniela Schikor,
Adolf Bauernfeind,
Erika C. Crouch and
Matthias Griese
Dr. von Haunersches Kinderspital, University of Munich, Munich, Germany; Department of Pathology, Washington University, School of Medicine, St. Louis, Missouri; and Max von Pettenkofer Institut, University of Munich, Munich, Germany
Address correspondence to: Matthias Griese, Dr. von Haunersches Kinderspital, University of Munich, Pettenkoferstrasse 8a, D-80336 Munich, Germany. E-mail: griese{at}pk-i.med.uni-muenchen.de
We investigated the role of the surfactant proteins (SPs) A and D in the pulmonary immune defense of nonmucoid strains of Pseudomonas aeruginosa, the most etiologic agents of nosocomial Pseudomonas pneumonia. We first examined the interactions of recombinant human SP-D dodecamers and purified natural or recombinant human SP-A with two smooth, and two rough, clinical isolates of nonmucoid P. aeruginosa. SP-D bound to all four isolates, but agglutinated only one rough and one smooth strain. SP-D functioned as an opsonin to enhance the uptake of all four strains by the human monocytic cell line Mono Mac 6 (MM6). SP-D also enhanced tumor necrosis factor- secretion by MM6 cells in response to purified lipopolysaccharide (LPS) isolated from the rough, but not the smooth, strains. Although SP-A bound to all four strains, it did not cause bacterial aggregation or enhance uptake. It showed small but statistically significant inhibitory effects on the cytokine response of MM6 cells to one strain of smooth organisms, but did not significantly alter the response to purified LPS. This study in combination with previously published data strongly suggests that SP-D may play important roles in the local innate pulmonary defense against nonmucoid P. aeruginosa of diverse LPS phenotypes, and preferentially augments the cellular response to rough P. aeruginosa endotoxin.
Abbreviations: colony-forming units, cfu ethylenediamine tetraacetic acid, EDTA fetal calf serum, FCS fluorescein isothiocyanate, FITC lipopolysaccharide, LPS Mono Mac 6, MM6 phosphate-buffered saline, PBS surfactant protein, SP Tris-buffered saline, TBS tumor necrosis factor, TNF
This article has been cited by other articles:

|
 |

|
 |
 
J. J. Mun, C. Tam, D. Kowbel, S. Hawgood, M. J. Barnett, D. J. Evans, and S. M. J. Fleiszig
Clearance of Pseudomonas aeruginosa from a Healthy Ocular Surface Involves Surfactant Protein D and Is Compromised by Bacterial Elastase in a Murine Null-Infection Model
Infect. Immun.,
June 1, 2009;
77(6):
2392 - 2398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sahly, Y. Keisari, E. Crouch, N. Sharon, and I. Ofek
Recognition of Bacterial Surface Polysaccharides by Lectins of the Innate Immune System and Its Contribution to Defense against Infection: the Case of Pulmonary Pathogens
Infect. Immun.,
April 1, 2008;
76(4):
1322 - 1332.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Giannoni, T. Sawa, L. Allen, J. Wiener-Kronish, and S. Hawgood
Surfactant Proteins A and D Enhance Pulmonary Clearance of Pseudomonas aeruginosa
Am. J. Respir. Cell Mol. Biol.,
June 1, 2006;
34(6):
704 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Casey, J. Kaplan, E. N. Atochina-Vasserman, A. J. Gow, H. Kadire, Y. Tomer, J. H. Fisher, S. Hawgood, R. C. Savani, and M. F. Beers
Alveolar Surfactant Protein D Content Modulates Bleomycin-induced Lung Injury
Am. J. Respir. Crit. Care Med.,
October 1, 2005;
172(7):
869 - 877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chaby, I. Garcia-Verdugo, Q. Espinassous, and L. A. Augusto
Interactions between LPS and lung surfactant proteins
Innate Immunity,
June 1, 2005;
11(3):
181 - 185.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Sadikot, T. S. Blackwell, J. W. Christman, and A. S. Prince
Pathogen-Host Interactions in Pseudomonas aeruginosa Pneumonia
Am. J. Respir. Crit. Care Med.,
June 1, 2005;
171(11):
1209 - 1223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ni, D. J. Evans, S. Hawgood, E. M. Anders, R. A. Sack, and S. M. J. Fleiszig
Surfactant Protein D Is Present in Human Tear Fluid and the Cornea and Inhibits Epithelial Cell Invasion by Pseudomonas aeruginosa
Infect. Immun.,
April 1, 2005;
73(4):
2147 - 2156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Schaeffer, F. X. McCormack, H. Wu, and A. A. Weiss
Interactions of Pulmonary Collectins with Bordetella bronchiseptica and Bordetella pertussis Lipopolysaccharide Elucidate the Structural Basis of Their Antimicrobial Activities
Infect. Immun.,
December 1, 2004;
72(12):
7124 - 7130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Griese, R. Essl, R. Schmidt, E. Rietschel, F. Ratjen, M. Ballmann, K. Paul, and for the BEAT Study Group
Pulmonary Surfactant, Lung Function, and Endobronchial Inflammation in Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
November 1, 2004;
170(9):
1000 - 1005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. O. Hirche, E. C. Crouch, M. Espinola, T. J. Brokelman, R. P. Mecham, N. DeSilva, J. Cooley, E. Remold-O'Donnell, and A. Belaaouaj
Neutrophil Serine Proteinases Inactivate Surfactant Protein D by Cleaving within a Conserved Subregion of the Carbohydrate Recognition Domain
J. Biol. Chem.,
June 25, 2004;
279(26):
27688 - 27698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. van de Wetering, F. E. J. Coenjaerts, A. B. Vaandrager, L. M. G. van Golde, and J. J. Batenburg
Aggregation of Cryptococcus neoformans by Surfactant Protein D Is Inhibited by Its Capsular Component Glucuronoxylomannan
Infect. Immun.,
January 1, 2004;
72(1):
145 - 153.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 American Thoracic Society.
|
|
|